Target intelligence / Profile preview

C-type lectin-like 1 (CLECL1)

Target
CLECL1
Molecular classification
Other (C-type lectin-like domain-containing pseudogene or putative protein)
01

Overview

C-type lectin-like 1 (CLECL1) encodes a type II transmembrane protein of the C-type lectin-like family, highly expressed on dendritic and B cells[1]. It is presumed to function as a T cell costimulatory molecule promoting interleukin-4 production and possibly participates in immune response regulation[1]. However, biological details remain limited, and there is significant ambiguity in the literature; in some contexts, CLECL1 may be referenced as a pseudogene[1][3]. CLECL1 is not a validated therapeutic target, and its precise signaling properties, endogenous ligands, or clinical disease roles remain poorly characterized[3]. The broader C-type lectin-like family encompasses receptors involved in immune recognition, cell adhesion, and immunoregulation, but specifically, CLECL1’s function, mechanism, and therapeutic relevance have not been clearly defined[2][3].

Other names
DCAL1DCAL-1DC-associated lectin-1Dendritic cell-associated lectin 1CLECL1PCLECL1C-type lectin-like domain family 1 pseudogene
02

Biological functions

Immune response (possible, based on presumed similarity to other C-type lectin-like molecules and expression pattern)[1]Signal transduction (possible, but not substantiated for the pseudogene/protein)
03

Disease associations

Other (no well-established disease associations)

Beyond the preview

Go deeper on C-type lectin-like 1 (CLECL1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on C-type lectin-like 1 (CLECL1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call